(Reuters) -Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, ...

Novavax raised its annual revenue forecast for the third time this year on Thursday, banking on milestone payments from ...

Discover Novavax's Q3 2025 earnings: partnership-driven strategy, cost savings, increased revenue outlook, and pipeline progress.

Novavax (NVAX) stock in focus as the company boosts 2025 revenue outlook after better than expected Q3 revenue driven by ...

Shares of Novavax Inc. NVAX shed 1.18% to $8.36 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.89% to ...

Shah Capital increased its stake to about 8.3% and said the gap between Novavax’s scientific potential and its commercial ...

The Minnesota Vikings don’t need a spark. “They need a time machine.” That’s how NFL insider Michael Silver described the state of the team’s quarterback situation. Sitting at 3-4, the Purple and Gold ...

Salmonella enterica serovar Paratyphi A (also known as S. Paratyphi A) is responsible for more than 2 million cases of enteric fever annually. There are no licensed vaccines against S. Paratyphi A. In ...

Jeb Teichman’s phone rang just before midnight. As a pediatrician, he has received many late-night emergency calls. This time, the call was about his 29-year-old son. Brent Teichmanhad been suffering ...